Ji‐Ho Park
KAIST 의료공학과 · 의학
Ji-Ho Park 교수의 연구실은 암 치료를 위한 다기능 나노소재 개발에 초점을 맞추고 있습니다. 특히 종양 표적화, 영상 진단, 약물 전달 기능을 통합한 하이브리드 나노입자 및 나노워름 형태의 자기 나노입자를 중심으로 연구를 진행하고 있으며, 암 세포에 특이적으로 침착하고 지속적인 순환 시간을 확보하는 데에 주력하고 있습니다. 나노입자의 형상, 표면 기능화 방식, 타겟팅 리간드의 밀도 및 종류 등 다양한 변수가 종양 축적에 미치는 영향을 체계적으로 분석하고 있습니다.
표시된 성과는 수집된 데이터 기준으로 산출되며, 일부 차이가 있을 수 있습니다.
The synthesis, in vitro, and in vivo behavior of tumor-homing magnetic nanoworms (NW) are described. The particles consist of a chainlike aggregation of iron oxide (IO) cores in a dextran coating. When conjugated with a tumor-targeting peptide, they interact more effectively with a tumor-based target in vitro relative to spherical nanoparticles. Untargeted NW display similar in vivo circulation times and enhanced passive accumulation in mouse xenograft tumors relative to untargeted spherical IO
Author Manuscript: 2012 May 29
There is currently considerable effort to incorporate both diagnostic and therapeutic functions into a single nanoscale system for the more effective treatment of cancer. Nanoparticles have great potential to achieve such dual functions, particularly if more than one type of nanostructure can be incorporated in a nanoassembly, referred to in this review as a hybrid nanoparticle. Here we review recent developments in the synthesis and evaluation of such hybrid nanoparticles based on two design st
Multimodal nanoassemblies that contain magnetic nanoparticles, quantum dots, and the anticancer drug doxorubicin within a single PEG–phospholipid micelle were prepared (see scheme; PEG=poly(ethylene glycol)). When equipped with the targeting peptide F3, these nanostructures enable simultaneous targeted drug delivery and dual-mode imaging of tumor tissues by near-infrared fluorescence and NMR spectroscopy.
A significant barrier to the clinical translation of systemically administered therapeutic nanoparticles is their tendency to be removed from circulation by the mononuclear phagocyte system. The addition of a targeting ligand that selectively interacts with cancer cells can improve the therapeutic efficacy of nanomaterials, although these systems have met with only limited success. Here, we present a cooperative nanosystem consisting of two discrete nanomaterials. The first component is gold nan
In the design of nanoparticles that can target disease tissue in vivo, parameters such as targeting ligand density, type of target receptor, and nanoparticle shape can play an important role in determining the extent of accumulation. Herein, a systematic study of these parameters for the targeting of mouse xenograft tumors is performed using superparamagnetic iron oxide as a model nanoparticle system. The type of targeting peptide (recognizing cell surface versus extracellular matrix), the surfa
Atherosclerotic plaques exhibit high deposition of cholesterol and macrophages. These are not only the main components of the plaques but also key inflammation-triggering sources. However, no existing therapeutics can achieve effective removal of both components within the plaques. Here, we report cargo-switching nanoparticles (CSNP) that are physicochemically designed to bind to cholesterol and release anti-inflammatory drug in the plaque microenvironment. CSNP have a core-shell structure with
Multimodale Nanoassoziate aus magnetischen Nanopartikeln, Quantenpunkten und dem Tumortherapeutikum Doxorubicin in einer einzigen PEG-Phospholipid-Micelle wurden hergestellt (siehe Schema; PEG=Polyethylenglycol). Wenn diese Nanostrukturen das Zielpeptid F3 enthielten, ermöglichten sie simultan die gezielte Wirkstofffreigabe und das duale Abbilden von Tumorgewebe durch Nah-IR-Fluoreszenz und NMR-Spektroskopie.
The kinetics of the isoprene−OH/OD reaction in the presence of O2 and NO have been studied using laser photolysis/laser-induced fluorescence. We report pressure and temperature-dependent rate constants for the addition of OH/OD to isoprene are in good agreement with previous studies. On the basis of simulations to OH cycling curves, we find a value of (9.0 ± 3.0) × 10-12 molecule-1 cm3 s-1 for the overall reaction rate constant of hydroxy peroxy radical with NO at 298 K. We report a rate constan